FENNEC PHARMACEUTICALS INC.·4

Jun 10, 5:27 PM ET

Cook Jodi A 4

Research Summary

AI-generated summary

Updated

Fennec Pharmaceuticals Director Jodi Cook Receives Option Award

What Happened
Jodi A. Cook, a director of Fennec Pharmaceuticals, was granted a non‑qualified stock option to acquire 20,000 shares on June 10, 2026. The option strike price is $8.70 per share (20,000 × $8.70 = $174,000 reported value). This filing reports an award (derivative grant), not a purchase or sale of underlying shares.

Key Details

  • Transaction date: 2026-06-10; transaction type: A (award/grant of derivative).
  • Grant: 20,000 stock options with exercise price $8.70; reported aggregate value $174,000.
  • Vesting: 100% vested on grant (per footnote). Options can be exercised immediately, but no exercise or sale is reported.
  • Shares owned after transaction: Not specified in this filing.
  • Timeliness: Filing dated 2026-06-10 (same date as transaction), so not indicated as late.

Context
A non‑qualified stock option is a compensation award that gives the holder the right to buy common shares at the stated strike ($8.70). Until exercised, the award is a derivative — it does not represent current share ownership or a market purchase. Grants are routine compensation for executives/directors and do not by themselves indicate buying/selling of stock.